| Filed On | Filing |
|---|---|
| 24 Mar 2023 |
8-K/A: Completion of Acquisition or Disposition of Assets
On January 23, 2023, Leap Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) disclosing the Company’s acquisition of Flame Biosciences, Inc., a Delaware corporation, pursuant to an Agreement a... |
| 15 Apr 2020 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
Loading...
